Australia markets closed

AVITA Medical, Inc. (RCEL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.52+0.22 (+2.65%)
At close: 04:00PM EDT
8.52 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 219.81M
Enterprise value 173.17M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.30
Price/book (mrq)4.48
Enterprise value/revenue 3.45
Enterprise value/EBITDA -5.16

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-45.66%
S&P500 52-week change 322.36%
52-week high 321.70
52-week low 38.01
50-day moving average 314.74
200-day moving average 314.47

Share statistics

Avg vol (3-month) 3234.14k
Avg vol (10-day) 3322.21k
Shares outstanding 525.8M
Implied shares outstanding 625.8M
Float 824.81M
% held by insiders 10.66%
% held by institutions 127.91%
Shares short (15 Apr 2024) 41.18M
Short ratio (15 Apr 2024) 43.97
Short % of float (15 Apr 2024) 44.61%
Short % of shares outstanding (15 Apr 2024) 44.59%
Shares short (prior month 15 Mar 2024) 4590.73k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 330 June 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -70.56%
Operating margin (ttm)-86.46%

Management effectiveness

Return on assets (ttm)-25.35%
Return on equity (ttm)-52.89%

Income statement

Revenue (ttm)50.14M
Revenue per share (ttm)1.98
Quarterly revenue growth (yoy)50.10%
Gross profit (ttm)N/A
EBITDA -41.94M
Net income avi to common (ttm)-35.38M
Diluted EPS (ttm)-1.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)89.06M
Total cash per share (mrq)3.46
Total debt (mrq)42.41M
Total debt/equity (mrq)86.45%
Current ratio (mrq)7.88
Book value per share (mrq)1.91

Cash flow statement

Operating cash flow (ttm)-38.01M
Levered free cash flow (ttm)-24.02M